ClinicalTrials.Veeva

Menu

Renal Protocol Protection in CKD Patients

Seoul National University logo

Seoul National University

Status

Active, not recruiting

Conditions

CKD
HCC

Treatments

Other: Standard dose CT contrast media
Other: low dose CT contrast media

Study type

Interventional

Funder types

Other

Identifiers

NCT04024514
SNUH-2019-0343

Details and patient eligibility

About

This study aims to investigate whether acceptable image quality is achievable using low contrast media dose and low keV imaging in chronic kidney disease.

Enrollment

52 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • High risk group for developing HCC
  • Scheduled contrast-enhanced CT for HCC diagnosis or surveillance
  • chronic kidney disease (Estimated GFR < 60mL/min/1.73m2)

Exclusion criteria

  • not a high risk group for developing HCC
  • congestive hepatopathy
  • on dialysis
  • no venous access on forearm
  • anticipated beam hardening artifact due to prosthesis
  • relative/absolute contra-indication of contrast-enhanced CT except CKD (Estimated GFR < 60mL/min/1.73m2)

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

52 participants in 2 patient groups

Low dose
Experimental group
Description:
Low CT contrast media dose
Treatment:
Other: low dose CT contrast media
Standard dose
Active Comparator group
Description:
Standard CT contrast media dose
Treatment:
Other: Standard dose CT contrast media

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems